← Leaderboards
Daniel Robert Goldstein
University Of Michigan At Ann Arbor
$17,752,903
Attributed
$21,646,353
Total exposure
14
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–23$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$21,646,353 · 14
By mechanism
R01$13,910,654 · 5
T32$2,274,660 · 1
R35$1,755,000 · 1
K08$1,253,610 · 2
R21$877,794 · 2
K02$737,100 · 1
Top collaborators
- Jane C Deng5 shared
- Lillian Chiang Min5 shared
- Lona Mody5 shared
- Richard J Bucala4 shared
- Tarek Fahmy2 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Kyung-Dall Lee$3,871,487
- Santhi K Ganesh$10,797,888
- Panduranga S Rao$5,421,260
- Douglas Earl Schaubel$12,013,133
- Stephanie Hane Kim$59,776
Others in their field
Top investigators on “Aging”
- Lawrence Corey · Fred Hutchinson Cancer Center$506,603,345
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$351,438,389
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$281,021,854
- George R Seage · Abt Associates, Inc.$218,167,298
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$210,610,900
Research focus
AgingImmuneAgedInsightVirus DiseasesAge RelatedViralImmunityToll-Like ReceptorsInflammationImmune ResponseClinical ResearchElderlyPathway InteractionsInfectionProductionBaseT-LymphocyteResponsePathogenExhibitsInfluenzaMorbidity - Disease RateLead
Grant awards (67)
Physician Scientist Training in Age-Related Diseases$607,576
T32 · FY2023 · AG
Role of mitophagy in age-related respiratory and vascular diseases$585,000
R35 · FY2023 · HL · contact PI
Physician Scientist Training in Age-Related Diseases$593,358
T32 · FY2022 · AG
Mechanisms of dysregulated immunity with aging$585,923
R01 · FY2022 · AG · contact PI
Role of mitophagy in age-related respiratory and vascular diseases$585,000
R35 · FY2022 · HL · contact PI
Novel mechanisms of age-enhanced vasculopathy after heart transplantation$496,580
R01 · FY2022 · AI · contact PI
NEXTGEN: Nurturing next generation of diverse research leaders by providing mentored research experiences$227,106
T32 · FY2022 · AG
Mechanisms of dysregulated immunity with aging$585,923
R01 · FY2021 · AG · contact PI
Role of mitophagy in age-related respiratory and vascular diseases$585,000
R35 · FY2021 · HL · contact PI
Physician Scientist Training in Age-Related Diseases$569,494
T32 · FY2021 · AG
Novel mechanisms of age-enhanced vasculopathy after heart transplantation$543,089
R01 · FY2021 · AI · contact PI
Mechanisms of dysregulated immunity with aging$592,344
R01 · FY2020 · AG · contact PI
Novel mechanisms of age-enhanced vasculopathy after heart transplantation$543,089
R01 · FY2020 · AI · contact PI
Physician Scientist Training in Age-Related Diseases$277,126
T32 · FY2020 · AG
Mechanisms of dysregulated immunity with aging$249,600
R01 · FY2020 · AG · contact PI
Mechanisms of dysregulated immunity with aging$642,138
R01 · FY2019 · AG · contact PI
Novel mechanisms of age-enhanced vasculopathy after heart transplantation$530,422
R01 · FY2019 · AI · contact PI
Novel Inflammatory Pathway of Aged-Enhanced Atherosclerosis$387,500
R01 · FY2019 · HL · contact PI
Academic leadership in the Biology of Aging and Cardiovascular Diseases$130,107
K07 · FY2019 · AG · contact PI
Novel mechanisms of age-enhanced vasculopathy after heart transplantation$539,907
R01 · FY2018 · AI · contact PI
Aging and Innate Immune Mechanisms in Pulmonary Infection$416,250
R01 · FY2018 · HL
Novel Inflammatory Pathway of Aged-Enhanced Atherosclerosis$387,500
R01 · FY2018 · HL · contact PI
Academic leadership in the Biology of Aging and Cardiovascular Diseases$130,107
K07 · FY2018 · AG · contact PI
Aging and Innate Immune Mechanisms in Pulmonary Infection$416,250
R01 · FY2017 · HL
Novel Inflammatory Pathway of Aged-Enhanced Atherosclerosis$387,500
R01 · FY2017 · HL · contact PI
Academic leadership in the Biology of Aging and Cardiovascular Diseases$130,107
K07 · FY2017 · AG · contact PI
Aging and Innate Immune Mechanisms in Pulmonary Infection$416,250
R01 · FY2016 · HL
Novel Inflammatory Pathway of Aged-Enhanced Atherosclerosis$387,500
R01 · FY2016 · HL · contact PI
Mechanisms of dysregulated immunity with aging$317,750
R01 · FY2016 · AG · contact PI
Academic leadership in the Biology of Aging and Cardiovascular Diseases$130,107
K07 · FY2016 · AG · contact PI
Aging and Innate Immune Mechanisms in Pulmonary Infection$416,250
R01 · FY2015 · HL
Mechanisms of dysregulated immunity with aging.$331,085
R01 · FY2015 · AG · contact PI
Academic leadership in the Biology of Aging and Cardiovascular Diseases$130,107
K07 · FY2015 · AG · contact PI
Mechanisms of dysregulated immunity with aging.$341,325
R01 · FY2014 · AG · contact PI
Nanotherapeutics for combined immunesuppression in organ transplantation$237,223
R21 · FY2014 · AI · contact PI
Mechanisms of dysregulated immunity with aging.$322,552
R01 · FY2013 · AG · contact PI
Nanotherapeutics for combined immunesuppression in organ transplantation$195,870
R21 · FY2013 · AI · contact PI
Hyaluronan as an innate ligand that induces inflammation after transplantation$195,638
R21 · FY2013 · AI · contact PI
Mechanisms of dysregulated immunity with aging.$290,471
R01 · FY2012 · AG · contact PI
Hyaluronan as an innate ligand that induces inflammation after transplantation$249,063
R21 · FY2012 · AI · contact PI
Aging, Viral Immunity and Atherosclerosis$147,420
K02 · FY2012 · AG · contact PI
Mechanisms to augment primary immunity in aging$116,200
R01 · FY2012 · AG · contact PI
Mechanisms to augment primary immunity in aging$317,467
R01 · FY2011 · AG · contact PI
The Role of Innate Immunity in Transplant Tolerance$187,000
R56 · FY2011 · AI · contact PI
Aging, Viral Immunity and Atherosclerosis$147,420
K02 · FY2011 · AG · contact PI
Mechanisms to augment primary immunity in aging$330,062
R01 · FY2010 · AG · contact PI
Role of Innate Immunity in Transplantation Tolerance$308,369
R01 · FY2010 · AI · contact PI
Aging, Viral Immunity and Atherosclerosis$147,420
K02 · FY2010 · AG · contact PI
Role of Innate Immunity in Transplantation Tolerance$116,454
R01 · FY2010 · AI · contact PI
Mechanisms to augment primary immunity in aging$481,330
R01 · FY2009 · AG · contact PI
Role of Innate Immunity in Transplantation Tolerance$311,484
R01 · FY2009 · AI · contact PI
Aging, Viral Immunity and Atherosclerosis$147,420
K02 · FY2009 · AG · contact PI
Mechanisms to augment primary immunity in aging$339,470
R01 · FY2008 · AG · contact PI
Role of Innate Immunity in Transplantation Tolerance$311,484
R01 · FY2008 · AI · contact PI
Mechanisms to augment primary immunity in aging$161,475
R01 · FY2008 · AG · contact PI
Aging, Viral Immunity and Atherosclerosis$147,420
K02 · FY2008 · AG · contact PI
Mechanisms to augment primary immunity in aging$345,144
R01 · FY2007 · AG · contact PI
Role of Innate Immunity in Transplantation Tolerance$317,517
R01 · FY2007 · AI · contact PI
Strategies to enhance immunity in aging$216,000
K08 · FY2007 · AG · contact PI
Role of Innate Immunity in Transplantation Tolerance$327,000
R01 · FY2006 · AI · contact PI
Strategies to enhance immunity in aging$216,000
K08 · FY2006 · AG · contact PI
Strategies to enhance immunity in aging$216,000
K08 · FY2005 · AG
MECHANISMS OF DONOR SPLEEN INDUCED TRANSPLANT TOLERANCE$126,900
K08 · FY2004 · AI
MECHANISMS OF DONOR SPLEEN INDUCED TRANSPLANT TOLERANCE$126,900
K08 · FY2003 · AI
MECHANISMS OF DONOR SPLEEN INDUCED TRANSPLANT TOLERANCE$126,900
K08 · FY2002 · AI
MECHANISMS OF DONOR SPLEEN INDUCED TRANSPLANT TOLERANCE$116,100
K08 · FY2001 · AI
MECHANISMS OF DONOR SPLEEN INDUCED TRANSPLANT TOLERANCE$108,810
K08 · FY2000 · AI